Click for best price
Cancer Tumor Profiling Market Size, Share 2024
| Market size in 2023 |
US$ 8738.6 million
|
Forecast Market size by 2030 |
US$ 18910 million
|
| Growth Rate |
CAGR of 11.8% |
Number of Pages |
104 Pages |
This research report provides a comprehensive analysis of the Cancer (Tumor) Profiling market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Cancer (Tumor) Profiling market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Cancer (Tumor) Profiling, challenges faced by the industry, and potential opportunities for market players.
The global Cancer (Tumor) Profiling market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Cancer (Tumor) Profiling market presents opportunities for various stakeholders, including Clinical, Research. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Cancer (Tumor) Profiling market. Additionally, the growing consumer demand present avenues for market expansion.
The global Cancer (Tumor) Profiling market was valued at US$ 8738.6 million in 2023 and is projected to reach US$ 18910 million by 2030, at a CAGR of 11.8% during the forecast period.
Surging cancer prevalence across the globe is one of the major factors contributing to the market growth. Cancer is the second leading cause of death worldwide. One in six deaths worldwide is due to cancer. In middle- and lower-class economies, 70% of deaths are due to cancer. This expands the growth scope of the market. Surging public-private funding of targeted research activities, emergence of cancer profiling relative to traditional methods of cancer diagnosis, increasing geriatric population base, and increasing product innovation and development due to technological advancements across the world will provide lucrative opportunities for market players. Estimated period 2022-2029. In addition, the surge in the number of strategic cooperations, rising Internet penetration, increasing number of hospitals and laboratories, increasing cases of lung cancer, prostate cancer, and acute leukemia, and increasing healthcare expenditure per capita will lead to further expansion of the market growth rate in the future.
Key Features:
The research report on the Cancer (Tumor) Profiling market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Cancer (Tumor) Profiling market.
Market Overview: The report provides a comprehensive overview of the Cancer (Tumor) Profiling market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Immunoassay, NGS), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Cancer (Tumor) Profiling market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Cancer (Tumor) Profiling market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Cancer (Tumor) Profiling market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Cancer (Tumor) Profiling market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Cancer (Tumor) Profiling market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Cancer (Tumor) Profiling market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Cancer (Tumor) Profiling, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Cancer (Tumor) Profiling market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Cancer (Tumor) Profiling market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Immunoassay
NGS
Mass Spectrometry
Others
Market segment by Application
Clinical
Research
Global Cancer (Tumor) Profiling Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Illumina
Qiagen
Neogenomics Laboratories
HTG Molecular Diagnostics
Genomic Health
Caris Life Sciences
Helomics Corporation
Nanostring Technologies
Oxford Gene Technology
Ribomed Biotechnologies
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer (Tumor) Profiling, market overview.
Chapter 2: Global Cancer (Tumor) Profiling market size in revenue.
Chapter 3: Detailed analysis of Cancer (Tumor) Profiling company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer (Tumor) Profiling in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Cancer (Tumor) Profiling Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 8738.6 million
|
| Forecast Market size by 2030 |
US$ 18910 million
|
| Growth Rate |
CAGR of 11.8% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
104 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer (Tumor) Profiling Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer (Tumor) Profiling Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer (Tumor) Profiling Overall Market Size
2.1 Global Cancer (Tumor) Profiling Market Size: 2023 VS 2030
2.2 Global Cancer (Tumor) Profiling Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer (Tumor) Profiling Players in Global Market
3.2 Top Global Cancer (Tumor) Profiling Companies Ranked by Revenue
3.3 Global Cancer (Tumor) Profiling Revenue by Companies
3.4 Top 3 and Top 5 Cancer (Tumor) Profiling Companies in Global Market, by Revenue in 2023
3.5 Global Companies Cancer (Tumor) Profiling Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer (Tumor) Profiling Players in Global Market
3.6.1 List of Global Tier 1 Cancer (Tumor) Profiling Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer (Tumor) Profiling Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer (Tumor) Profiling Market Size Markets, 2023 & 2030
4.1.2 Immunoassay
4.1.3 NGS
4.1.4 Mass Spectrometry
4.1.5 Others
4.2 By Type - Global Cancer (Tumor) Profiling Revenue & Forecasts
4.2.1 By Type - Global Cancer (Tumor) Profiling Revenue, 2019-2024
4.2.2 By Type - Global Cancer (Tumor) Profiling Revenue, 2025-2030
4.2.3 By Type - Global Cancer (Tumor) Profiling Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer (Tumor) Profiling Market Size, 2023 & 2030
5.1.2 Clinical
5.1.3 Research
5.2 By Application - Global Cancer (Tumor) Profiling Revenue & Forecasts
5.2.1 By Application - Global Cancer (Tumor) Profiling Revenue, 2019-2024
5.2.2 By Application - Global Cancer (Tumor) Profiling Revenue, 2025-2030
5.2.3 By Application - Global Cancer (Tumor) Profiling Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Cancer (Tumor) Profiling Market Size, 2023 & 2030
6.2 By Region - Global Cancer (Tumor) Profiling Revenue & Forecasts
6.2.1 By Region - Global Cancer (Tumor) Profiling Revenue, 2019-2024
6.2.2 By Region - Global Cancer (Tumor) Profiling Revenue, 2025-2030
6.2.3 By Region - Global Cancer (Tumor) Profiling Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Cancer (Tumor) Profiling Revenue, 2019-2030
6.3.2 US Cancer (Tumor) Profiling Market Size, 2019-2030
6.3.3 Canada Cancer (Tumor) Profiling Market Size, 2019-2030
6.3.4 Mexico Cancer (Tumor) Profiling Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Cancer (Tumor) Profiling Revenue, 2019-2030
6.4.2 Germany Cancer (Tumor) Profiling Market Size, 2019-2030
6.4.3 France Cancer (Tumor) Profiling Market Size, 2019-2030
6.4.4 U.K. Cancer (Tumor) Profiling Market Size, 2019-2030
6.4.5 Italy Cancer (Tumor) Profiling Market Size, 2019-2030
6.4.6 Russia Cancer (Tumor) Profiling Market Size, 2019-2030
6.4.7 Nordic Countries Cancer (Tumor) Profiling Market Size, 2019-2030
6.4.8 Benelux Cancer (Tumor) Profiling Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Cancer (Tumor) Profiling Revenue, 2019-2030
6.5.2 China Cancer (Tumor) Profiling Market Size, 2019-2030
6.5.3 Japan Cancer (Tumor) Profiling Market Size, 2019-2030
6.5.4 South Korea Cancer (Tumor) Profiling Market Size, 2019-2030
6.5.5 Southeast Asia Cancer (Tumor) Profiling Market Size, 2019-2030
6.5.6 India Cancer (Tumor) Profiling Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Cancer (Tumor) Profiling Revenue, 2019-2030
6.6.2 Brazil Cancer (Tumor) Profiling Market Size, 2019-2030
6.6.3 Argentina Cancer (Tumor) Profiling Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer (Tumor) Profiling Revenue, 2019-2030
6.7.2 Turkey Cancer (Tumor) Profiling Market Size, 2019-2030
6.7.3 Israel Cancer (Tumor) Profiling Market Size, 2019-2030
6.7.4 Saudi Arabia Cancer (Tumor) Profiling Market Size, 2019-2030
6.7.5 UAE Cancer (Tumor) Profiling Market Size, 2019-2030
7 Cancer (Tumor) Profiling Companies Profiles
7.1 Illumina
7.1.1 Illumina Company Summary
7.1.2 Illumina Business Overview
7.1.3 Illumina Cancer (Tumor) Profiling Major Product Offerings
7.1.4 Illumina Cancer (Tumor) Profiling Revenue in Global Market (2019-2024)
7.1.5 Illumina Key News & Latest Developments
7.2 Qiagen
7.2.1 Qiagen Company Summary
7.2.2 Qiagen Business Overview
7.2.3 Qiagen Cancer (Tumor) Profiling Major Product Offerings
7.2.4 Qiagen Cancer (Tumor) Profiling Revenue in Global Market (2019-2024)
7.2.5 Qiagen Key News & Latest Developments
7.3 Neogenomics Laboratories
7.3.1 Neogenomics Laboratories Company Summary
7.3.2 Neogenomics Laboratories Business Overview
7.3.3 Neogenomics Laboratories Cancer (Tumor) Profiling Major Product Offerings
7.3.4 Neogenomics Laboratories Cancer (Tumor) Profiling Revenue in Global Market (2019-2024)
7.3.5 Neogenomics Laboratories Key News & Latest Developments
7.4 HTG Molecular Diagnostics
7.4.1 HTG Molecular Diagnostics Company Summary
7.4.2 HTG Molecular Diagnostics Business Overview
7.4.3 HTG Molecular Diagnostics Cancer (Tumor) Profiling Major Product Offerings
7.4.4 HTG Molecular Diagnostics Cancer (Tumor) Profiling Revenue in Global Market (2019-2024)
7.4.5 HTG Molecular Diagnostics Key News & Latest Developments
7.5 Genomic Health
7.5.1 Genomic Health Company Summary
7.5.2 Genomic Health Business Overview
7.5.3 Genomic Health Cancer (Tumor) Profiling Major Product Offerings
7.5.4 Genomic Health Cancer (Tumor) Profiling Revenue in Global Market (2019-2024)
7.5.5 Genomic Health Key News & Latest Developments
7.6 Caris Life Sciences
7.6.1 Caris Life Sciences Company Summary
7.6.2 Caris Life Sciences Business Overview
7.6.3 Caris Life Sciences Cancer (Tumor) Profiling Major Product Offerings
7.6.4 Caris Life Sciences Cancer (Tumor) Profiling Revenue in Global Market (2019-2024)
7.6.5 Caris Life Sciences Key News & Latest Developments
7.7 Helomics Corporation
7.7.1 Helomics Corporation Company Summary
7.7.2 Helomics Corporation Business Overview
7.7.3 Helomics Corporation Cancer (Tumor) Profiling Major Product Offerings
7.7.4 Helomics Corporation Cancer (Tumor) Profiling Revenue in Global Market (2019-2024)
7.7.5 Helomics Corporation Key News & Latest Developments
7.8 Nanostring Technologies
7.8.1 Nanostring Technologies Company Summary
7.8.2 Nanostring Technologies Business Overview
7.8.3 Nanostring Technologies Cancer (Tumor) Profiling Major Product Offerings
7.8.4 Nanostring Technologies Cancer (Tumor) Profiling Revenue in Global Market (2019-2024)
7.8.5 Nanostring Technologies Key News & Latest Developments
7.9 Oxford Gene Technology
7.9.1 Oxford Gene Technology Company Summary
7.9.2 Oxford Gene Technology Business Overview
7.9.3 Oxford Gene Technology Cancer (Tumor) Profiling Major Product Offerings
7.9.4 Oxford Gene Technology Cancer (Tumor) Profiling Revenue in Global Market (2019-2024)
7.9.5 Oxford Gene Technology Key News & Latest Developments
7.10 Ribomed Biotechnologies
7.10.1 Ribomed Biotechnologies Company Summary
7.10.2 Ribomed Biotechnologies Business Overview
7.10.3 Ribomed Biotechnologies Cancer (Tumor) Profiling Major Product Offerings
7.10.4 Ribomed Biotechnologies Cancer (Tumor) Profiling Revenue in Global Market (2019-2024)
7.10.5 Ribomed Biotechnologies Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer (Tumor) Profiling Market Opportunities & Trends in Global Market
Table 2. Cancer (Tumor) Profiling Market Drivers in Global Market
Table 3. Cancer (Tumor) Profiling Market Restraints in Global Market
Table 4. Key Players of Cancer (Tumor) Profiling in Global Market
Table 5. Top Cancer (Tumor) Profiling Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Cancer (Tumor) Profiling Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Cancer (Tumor) Profiling Revenue Share by Companies, 2019-2024
Table 8. Global Companies Cancer (Tumor) Profiling Product Type
Table 9. List of Global Tier 1 Cancer (Tumor) Profiling Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer (Tumor) Profiling Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Cancer (Tumor) Profiling Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Cancer (Tumor) Profiling Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Cancer (Tumor) Profiling Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Cancer (Tumor) Profiling Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Cancer (Tumor) Profiling Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Cancer (Tumor) Profiling Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Cancer (Tumor) Profiling Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Cancer (Tumor) Profiling Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Cancer (Tumor) Profiling Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Cancer (Tumor) Profiling Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Cancer (Tumor) Profiling Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Cancer (Tumor) Profiling Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Cancer (Tumor) Profiling Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Cancer (Tumor) Profiling Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Cancer (Tumor) Profiling Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Cancer (Tumor) Profiling Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Cancer (Tumor) Profiling Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Cancer (Tumor) Profiling Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Cancer (Tumor) Profiling Revenue, (US$, Mn), 2025-2030
Table 30. Illumina Company Summary
Table 31. Illumina Cancer (Tumor) Profiling Product Offerings
Table 32. Illumina Cancer (Tumor) Profiling Revenue (US$, Mn) & (2019-2024)
Table 33. Illumina Key News & Latest Developments
Table 34. Qiagen Company Summary
Table 35. Qiagen Cancer (Tumor) Profiling Product Offerings
Table 36. Qiagen Cancer (Tumor) Profiling Revenue (US$, Mn) & (2019-2024)
Table 37. Qiagen Key News & Latest Developments
Table 38. Neogenomics Laboratories Company Summary
Table 39. Neogenomics Laboratories Cancer (Tumor) Profiling Product Offerings
Table 40. Neogenomics Laboratories Cancer (Tumor) Profiling Revenue (US$, Mn) & (2019-2024)
Table 41. Neogenomics Laboratories Key News & Latest Developments
Table 42. HTG Molecular Diagnostics Company Summary
Table 43. HTG Molecular Diagnostics Cancer (Tumor) Profiling Product Offerings
Table 44. HTG Molecular Diagnostics Cancer (Tumor) Profiling Revenue (US$, Mn) & (2019-2024)
Table 45. HTG Molecular Diagnostics Key News & Latest Developments
Table 46. Genomic Health Company Summary
Table 47. Genomic Health Cancer (Tumor) Profiling Product Offerings
Table 48. Genomic Health Cancer (Tumor) Profiling Revenue (US$, Mn) & (2019-2024)
Table 49. Genomic Health Key News & Latest Developments
Table 50. Caris Life Sciences Company Summary
Table 51. Caris Life Sciences Cancer (Tumor) Profiling Product Offerings
Table 52. Caris Life Sciences Cancer (Tumor) Profiling Revenue (US$, Mn) & (2019-2024)
Table 53. Caris Life Sciences Key News & Latest Developments
Table 54. Helomics Corporation Company Summary
Table 55. Helomics Corporation Cancer (Tumor) Profiling Product Offerings
Table 56. Helomics Corporation Cancer (Tumor) Profiling Revenue (US$, Mn) & (2019-2024)
Table 57. Helomics Corporation Key News & Latest Developments
Table 58. Nanostring Technologies Company Summary
Table 59. Nanostring Technologies Cancer (Tumor) Profiling Product Offerings
Table 60. Nanostring Technologies Cancer (Tumor) Profiling Revenue (US$, Mn) & (2019-2024)
Table 61. Nanostring Technologies Key News & Latest Developments
Table 62. Oxford Gene Technology Company Summary
Table 63. Oxford Gene Technology Cancer (Tumor) Profiling Product Offerings
Table 64. Oxford Gene Technology Cancer (Tumor) Profiling Revenue (US$, Mn) & (2019-2024)
Table 65. Oxford Gene Technology Key News & Latest Developments
Table 66. Ribomed Biotechnologies Company Summary
Table 67. Ribomed Biotechnologies Cancer (Tumor) Profiling Product Offerings
Table 68. Ribomed Biotechnologies Cancer (Tumor) Profiling Revenue (US$, Mn) & (2019-2024)
Table 69. Ribomed Biotechnologies Key News & Latest Developments
List of Figures
Figure 1. Cancer (Tumor) Profiling Segment by Type in 2023
Figure 2. Cancer (Tumor) Profiling Segment by Application in 2023
Figure 3. Global Cancer (Tumor) Profiling Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Cancer (Tumor) Profiling Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Cancer (Tumor) Profiling Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer (Tumor) Profiling Revenue in 2023
Figure 8. By Type - Global Cancer (Tumor) Profiling Revenue Market Share, 2019-2030
Figure 9. By Application - Global Cancer (Tumor) Profiling Revenue Market Share, 2019-2030
Figure 10. By Type - Global Cancer (Tumor) Profiling Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Cancer (Tumor) Profiling Revenue Market Share, 2019-2030
Figure 12. By Application - Global Cancer (Tumor) Profiling Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Cancer (Tumor) Profiling Revenue Market Share, 2019-2030
Figure 14. By Region - Global Cancer (Tumor) Profiling Revenue Market Share, 2019-2030
Figure 15. By Country - North America Cancer (Tumor) Profiling Revenue Market Share, 2019-2030
Figure 16. US Cancer (Tumor) Profiling Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Cancer (Tumor) Profiling Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Cancer (Tumor) Profiling Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Cancer (Tumor) Profiling Revenue Market Share, 2019-2030
Figure 20. Germany Cancer (Tumor) Profiling Revenue, (US$, Mn), 2019-2030
Figure 21. France Cancer (Tumor) Profiling Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Cancer (Tumor) Profiling Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Cancer (Tumor) Profiling Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Cancer (Tumor) Profiling Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Cancer (Tumor) Profiling Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Cancer (Tumor) Profiling Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Cancer (Tumor) Profiling Revenue Market Share, 2019-2030
Figure 28. China Cancer (Tumor) Profiling Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Cancer (Tumor) Profiling Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Cancer (Tumor) Profiling Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Cancer (Tumor) Profiling Revenue, (US$, Mn), 2019-2030
Figure 32. India Cancer (Tumor) Profiling Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Cancer (Tumor) Profiling Revenue Market Share, 2019-2030
Figure 34. Brazil Cancer (Tumor) Profiling Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Cancer (Tumor) Profiling Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Cancer (Tumor) Profiling Revenue Market Share, 2019-2030
Figure 37. Turkey Cancer (Tumor) Profiling Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Cancer (Tumor) Profiling Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Cancer (Tumor) Profiling Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Cancer (Tumor) Profiling Revenue, (US$, Mn), 2019-2030
Figure 41. Illumina Cancer (Tumor) Profiling Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Qiagen Cancer (Tumor) Profiling Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Neogenomics Laboratories Cancer (Tumor) Profiling Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. HTG Molecular Diagnostics Cancer (Tumor) Profiling Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Genomic Health Cancer (Tumor) Profiling Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Caris Life Sciences Cancer (Tumor) Profiling Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Helomics Corporation Cancer (Tumor) Profiling Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Nanostring Technologies Cancer (Tumor) Profiling Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Oxford Gene Technology Cancer (Tumor) Profiling Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Ribomed Biotechnologies Cancer (Tumor) Profiling Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
